5 Stocks With Big Insider Buying
Repligen
A biotech stock that insiders are active in here is Repligen (RGEN), which engages in the manufacture and supply of biologic products used to manufacture biologic drugs. Insiders are buying this stock into some solid strength, since shares are up a whopping 78% so far in 2012.
>>4 Biotech Stocks Under $10 Soaring Higher
Repligen has a market cap of $191 million and an enterprise value of $166 million. This stock trades at a premium valuation, with a trailing price-to-earnings of 154 and a forward price-to-earnings of 32. This is a cash-rich company, since the total cash position on its balance sheet is $28.38 million and its total debt is zero. A director just bought 10,000 shares, or around $60,000 worth of stock, at $6.08 per share. From a technical perspective, RGEN is currently trading above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending extremely strong for the last three months, with shares soaring higher from a low of $3.78 to its recent high of $6.36 a share. During that uptrend, shares of RGEN have consistently made higher lows and higher highs, which is bullish technical price action. That move has now pushed RGEN within range of triggering a near-term breakout trade. If you're bullish on RGEN, then I would look for long-biased trades once it manages to break out above some near-term overhead resistance at $6.36 a share with high volume. Look for a sustained move or close above $6.36 with volume that hits near or above its three-month average action of 158,098 shares. If that breakout triggers soon, then RGEN will have a great chance of re-testing or possibly taking out its next major overhead resistance level at $7.29 a share. Traders can look to buy RGEN off any weakness to anticipate that breakout and simply use a stop that sits just below $5.80 to $5.32 a share. You could also use a stop at around its 50-day moving average of $5.08 a share, depending on if you want to give it more room.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
